We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDY icon
1326
Dr. Reddy's Laboratories
RDY
$9.8B
$94K ﹤0.01%
10,715
TDW icon
1327
Tidewater
TDW
$3.91B
$94K ﹤0.01%
60
-10
-14% -$16.3K
AMID
1328
DELISTED
American Midstream Partners, LP
AMID
$94K ﹤0.01%
+3,700
New +$94.3K
MFA
1329
MFA Financial
MFA
$927M
$93K ﹤0.01%
3,035
-500
-14% -$15K
TOL icon
1330
Toll Brothers
TOL
$14.1B
$93K ﹤0.01%
2,634
+1,340
+104% +$49.3K
SPLK
1331
DELISTED
Splunk Inc
SPLK
$93K ﹤0.01%
1,310
NATI
1332
DELISTED
National Instruments Corp
NATI
$93K ﹤0.01%
3,256
ALLE icon
1333
Allegion
ALLE
$13.4B
$92K ﹤0.01%
1,785
-2,310
-56% -$116K
ISRG icon
1334
Intuitive Surgical
ISRG
$128B
$92K ﹤0.01%
1,926
-3,960
-67% -$187K
RJF icon
1335
Raymond James Financial
RJF
$33.3B
$92K ﹤0.01%
2,484
+2,467
+14,512% +$86.2K
VGR
1336
DELISTED
Vector Group Ltd.
VGR
$92K ﹤0.01%
8,206
+8,125
+10,031% +$81.5K
METR
1337
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
$92K ﹤0.01%
4,386
DFZ
1338
DELISTED
BARRY (R.G.) CORPORATION
DFZ
$92K ﹤0.01%
+4,913
New +$91.3K
BIB icon
1339
ProShares Ultra NASDAQ Biotechnology
BIB
$82.8M
$91K ﹤0.01%
2,300
-1,980
-46% -$89.9K
CERS icon
1340
Cerus
CERS
$615M
$91K ﹤0.01%
19,000
MGV icon
1341
Vanguard Mega Cap Value ETF
MGV
$13.3B
$91K ﹤0.01%
+1,625
New +$88.5K
CASS icon
1342
Cass Information Systems
CASS
$705M
$90K ﹤0.01%
2,306
+1,701
+281% +$72.3K
ETR icon
1343
Entergy
ETR
$53.1B
$90K ﹤0.01%
2,726
-1,220
-31% -$38.6K
IMO icon
1344
Imperial Oil
IMO
$60.8B
$90K ﹤0.01%
1,950
-80
-4% -$3.49K
MD icon
1345
Pediatrix Medical
MD
$2.15B
$90K ﹤0.01%
1,461
-426
-23% -$24.8K
RXL icon
1346
ProShares Ultra Health Care
RXL
$85.3M
$90K ﹤0.01%
8,000
-800
-9% -$8.83K
GTU
1347
DELISTED
CENTRAL GOLD TR (CANADA)
GTU
$90K ﹤0.01%
2,000
EIS icon
1348
iShares MSCI Israel ETF
EIS
$892M
$89K ﹤0.01%
1,700
OLED icon
1349
Universal Display
OLED
$3.81B
$89K ﹤0.01%
2,800
+1,800
+180% +$59.8K
PPLT
1350
abrdn Physical Platinum Shares ETF
PPLT
$1.85B
$89K ﹤0.01%
6,470

Similar funds

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.